Latest News Olga UKrainskaya 02/06/2023 Olga UKrainskaya 02/06/2023 Meet Crystec at #BIO2023 Read More Daniel Ledger 13/02/2023 Daniel Ledger 13/02/2023 BioNow Technical Service of the Year Award 2022 Read More Haleemah Amjid 10/03/2022 Haleemah Amjid 10/03/2022 Therapeutic Area Partnerships: Accelerating Innovation in Women's Health Read More Haleemah Amjid 18/02/2022 Haleemah Amjid 18/02/2022 Limiting the impact respiratory disease treatments have on the environment Read More Haleemah Amjid 02/11/2021 Haleemah Amjid 02/11/2021 Crystec to present mSAS® technology at RSC conference Read More Haleemah Amjid 28/10/2021 Haleemah Amjid 28/10/2021 Crystec’s mSAS® technology shortlisted for CPhI Award Read More Emily Bevis 19/10/2021 Emily Bevis 19/10/2021 A collaboration to enhance the delivery of biotherapeutics and generate transformative therapies for patients Read More Becky Murphy 25/08/2021 Becky Murphy 25/08/2021 New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2 Read More Older Posts
Daniel Ledger 13/02/2023 Daniel Ledger 13/02/2023 BioNow Technical Service of the Year Award 2022 Read More
Haleemah Amjid 10/03/2022 Haleemah Amjid 10/03/2022 Therapeutic Area Partnerships: Accelerating Innovation in Women's Health Read More
Haleemah Amjid 18/02/2022 Haleemah Amjid 18/02/2022 Limiting the impact respiratory disease treatments have on the environment Read More
Haleemah Amjid 02/11/2021 Haleemah Amjid 02/11/2021 Crystec to present mSAS® technology at RSC conference Read More
Haleemah Amjid 28/10/2021 Haleemah Amjid 28/10/2021 Crystec’s mSAS® technology shortlisted for CPhI Award Read More
Emily Bevis 19/10/2021 Emily Bevis 19/10/2021 A collaboration to enhance the delivery of biotherapeutics and generate transformative therapies for patients Read More
Becky Murphy 25/08/2021 Becky Murphy 25/08/2021 New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2 Read More
